Skip to main content

Medical Properties Trust, Inc.

corporate_fare Company Profile

Medical Properties Trust, Inc.

MPT·NYSE·Real Estate & Construction·CIK 0001287865

Medical Properties Trust, Inc. is a self-advised Real Estate Investment Trust (REIT) formed in 2003 to acquire and develop net-leased healthcare facilities. The company has operated as a REIT since April 6, 2004. As of December 31, 2025, the company held investments in 384 facilities with approximately 39,000 licensed beds across 31 states in the U.S., seven countries in Europe, and Colombia in South America. The company conducts substantially all of its business through MPT Operating Partnership, L.P. Its primary business strategy involves acquiring and developing healthcare facilities and leasing them to healthcare operating companies under long-term net leases. These leases require the tenant to cover most property-related costs. While the majority of leased assets are 100% owned, some are held through joint ventures, referred to as investments in unconsolidated real estate joint ventures. The company also provides mortgage loans to healthcare operators, secured by their real estate assets. Additionally, it may issue loans to certain operators via its taxable REIT subsidiaries (TRS), typically for working capital. From time to time, the company makes noncontrolling investments in its tenants, known as investments in unconsolidated operating entities, usually alongside larger real estate transactions. This business model supports acquisitions and recapitalizations, enabling healthcare operators to access capital by leveraging their real estate assets for improvements, technology upgrades, and other operational investments.

Medical Properties Trust, Inc. (NYSE:MPT) is a publicly traded company in the Real Estate & Construction sector. Wiseek has independently scored 10 items for MPT at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-17, rated 7/10. Across its 10 most recent items scored 7 or higher, the top rating is 9/10, with 7 rated 8 or above. Recent SEC coverage for MPT spans 10-Q, 8-K, 10-K.

Recent high-impact activity:

  • MPT Sells Two Hospitals for $413M, Boosting Q3 Cash Proceeds to $680M
  • MPT Q2 2026: Revenue Gains and Refinancing Tempered by Impairments and Rising Interest Costs
  • MPT Posts Q2 Loss, Shares Slide 6.6% Despite $2.4B Refinancing
  • MPT Lands $2.4B Refinancing, Pushes Maturities to 2032 and Cuts Debt by $123M
  • Infracore IPO Shares Fall on Swiss Debut, Impacting Major Shareholder MPT

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$972.02M
Net Income
-$277.05M
Diluted EPS
-$0.46
Op. Cash Flow
$230.77M
Free Cash Flow
$88.68M
Gross Profit
$881.72M
Cash & Equivalents
$540.86M
Total Debt
$9.7B
Debt / Equity
2.11×
Net Margin
-28.5%
Shares Outstanding
597.01M sh
Source: 10-K · filed 2026-02-26 · accession 0001193125-26-073587

Short Interest & Short Volume

15.13 days to cover

FINRA reported short interest of 145,296,024 shares in MPT as of the September 15, 2026 settlement, a 3.2% decrease from the prior period — about 15.1 days to cover at its recent average daily volume. On October 2, 2026, 64.5% of MPT volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)145,296,024 shares as of September 15, 2026
Change vs prior period▼ 3.2%
Days to cover15.13 at avg daily volume of 9,603,035
Daily short volume (FINRA facilities)64.5% of 7,610,750 shares on October 2, 2026
5-day average short volume58.5%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with M →
$3.29 +0.02% today
52-week range · as of 2026-08-10 $3.29 – $6.47
Market cap
$1.95B
Volume
13.8M (1.3× avg)
3-mo avg 10.3M
Live data · 2026-10-05 02:03 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed MPT - Latest Insights

MPT
Sep 17, 2026, 11:09 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $3.65
Real-time Price: $3.29 info
Change: -$0.3603 (-10%) info
Market Cap: $1.953B info
MPT
Aug 10, 2026, 4:52 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.20
Real-time Price: $3.29 info
Change: -$0.9103 (-22%) info
Market Cap: $1.953B info
MPT
Aug 10, 2026, 9:39 AM EDT
Source: BayStreet
Importance Score:
8
Price at Filing: $4.27
Real-time Price: $3.29 info
Change: -$0.9753 (-23%) info
Market Cap: $1.953B info
MPT
Aug 10, 2026, 9:25 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $4.61
Real-time Price: $3.29 info
Change: -$1.32 (-29%) info
Market Cap: $1.953B info
MPT
Jul 09, 2026, 4:25 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $4.48
Real-time Price: $3.29 info
Change: -$1.19 (-27%) info
Market Cap: $1.953B info
MPT
Jun 01, 2026, 4:55 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.05
Real-time Price: $3.29 info
Change: -$1.76 (-35%) info
Market Cap: $1.953B info
MPT
May 08, 2026, 4:20 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $5.17
Real-time Price: $3.29 info
Change: -$1.88 (-36%) info
Market Cap: $1.953B info
MPT
Apr 30, 2026, 8:20 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.14
Real-time Price: $3.29 info
Change: -$1.85 (-36%) info
Market Cap: $1.953B info
MPT
Feb 26, 2026, 8:31 AM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $5.76
Real-time Price: $3.29 info
Change: -$2.47 (-43%) info
Market Cap: $1.953B info
MPT
Feb 19, 2026, 8:30 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.60
Real-time Price: $3.29 info
Change: -$2.31 (-41%) info
Market Cap: $1.953B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets